Stock DHB DELIVRA HEALTH BRANDS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Delivra Health Brands Inc.

Equities

DHB

CA24703H1029

Pharmaceuticals

Market Closed - Toronto S.E.
Other stock markets
 01:44:16 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.035 CAD -12.50% Intraday chart for Delivra Health Brands Inc. +16.67% +75.00%
Apr. 09 Delivra Health Brands Inc.'s Dream Water Brand to Launch Its Immunity Support Sleep Shot in the Canadian Market CI
Feb. 27 Delivra Health Brands Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI

Valuation

Fiscal Period: Juni 2019 2022 2023 2024 2025
Capitalization 1 133.8 7.579 2.526 10.94 -
Enterprise Value (EV) 1 133.8 7.579 2.526 10.94 10.94
P/E ratio - -1 x - -35 x 35 x
Yield - - - - -
Capitalization / Revenue 11.7 x - 0.26 x 0.88 x 0.79 x
EV / Revenue 11.7 x - 0.26 x 0.88 x 0.79 x
EV / EBITDA -8.96 x - 4.89 x 8.8 x 6.55 x
EV / FCF - - - 14.6 x -
FCF Yield - - - 6.85% -
Price to Book - - - - -
Nbr of stocks (in thousands) 185,820 252,618 252,618 312,618 -
Reference price 2 0.7200 0.0300 0.0100 0.0350 0.0350
Announcement Date 10/28/19 10/28/22 10/18/23 - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2019 2022 2023 2024 2025
Net sales 1 11.46 - 9.791 12.44 13.93
EBITDA 1 -14.94 - 0.517 1.243 1.671
EBIT 1 - - -0.813 -0.106 0.294
Operating Margin - - -8.3% -0.85% 2.11%
Earnings before Tax (EBT) 1 - - - -0.224 0.177
Net income 1 - -7.009 - -0.224 0.163
Net margin - - - -1.8% 1.17%
EPS 2 - -0.0300 - -0.001000 0.001000
Free Cash Flow 1 - - - 0.749 -
FCF margin - - - 6.02% -
FCF Conversion (EBITDA) - - - 60.26% -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 10/28/19 10/28/22 10/18/23 - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: June 2023 Q3
Net sales -
EBITDA -
EBIT -
Operating Margin -
Earnings before Tax (EBT) -
Net income 1 -0.685
Net margin -
EPS 2 -0.003000
Dividend per Share -
Announcement Date 5/23/23
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2019 2022 2023 2024 2025
Net Debt - - - - -
Net Cash position - - - - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow 1 - - - 0.75 -
ROE (net income / shareholders' equity) - - - - -
ROA (Net income/ Total Assets) - - - - -
Assets 1 - - - - -
Book Value Per Share - - - - -
Cash Flow per Share - - - - -
Capex 1 - - - 0.1 0.1
Capex / Sales - - - 0.8% 0.72%
Announcement Date 10/28/19 10/28/22 10/18/23 - -
1CAD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.035 CAD
Average target price
0.07 CAD
Spread / Average Target
+100.00%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Recreational Pharmaceuticals

1st Jan change Capi.
DELIVRA HEALTH BRANDS INC. Stock Delivra Health Brands Inc.
+75.00% 7.99M
CURALEAF HOLDINGS, INC. Stock Curaleaf Holdings, Inc.
+23.05% 3.66B
TRULIEVE CANNABIS CORP. Stock Trulieve Cannabis Corp.
+109.78% 2B
GOODNESS GROWTH HOLDINGS, INC. Stock Goodness Growth Holdings, Inc.
+87.30% 61.69M
Recreational Pharmaceuticals
  1. Stock Market
  2. Equities
  3. DHB Stock
  4. Financials Delivra Health Brands Inc.